Drooid Logo
Back to story perspectives

Full Breakdown

FDA Removes Warnings on Ineffective Autism Treatments: Implications and Reactions

2/19/2026, 7:44:16 AM

Core Event: Removal of FDA Warnings

In late 2025, the Food and Drug Administration (FDA) removed a webpage that warned against various unproven and potentially harmful treatments for autism, including chlorine dioxide, raw camel milk, and chelation therapies. This decision has sparked significant concern among autism advocates and health professionals, who argue that the absence of these warnings could endanger vulnerable populations.

Background & Context: The Role of the FDA

The FDA's previous warnings highlighted the dangers of certain products marketed as autism treatments, emphasizing that they could pose significant health risks. The Department of Health and Human Services (HHS) stated that the page was retired during a routine cleanup of outdated content, as it had not been updated since 2019. Critics, however, argue that the removal of these warnings is ill-timed and irresponsible, given ongoing concerns about alternative treatments.

Key Figures & Groups: Robert F. Kennedy Jr. and Advocacy Organizations

Robert F. Kennedy Jr., the current HHS Secretary, has been a controversial figure due to his long-standing opposition to vaccines and promotion of alternative therapies. Under his leadership, the HHS has appointed individuals who advocate for unproven treatments, raising alarms among autism researchers and advocates. Zoe Gross, director at the Autistic Self Advocacy Network, stated, “People are still being preyed on by these alternative treatments like chelation and chlorine dioxide. Those can both kill people.”

Criticism & Opposition: Concerns from Experts

Health experts have expressed alarm over the FDA's decision. Dr. Paul Offit, a pediatrician, criticized Kennedy's approach, suggesting that it favors "bogus therapies" over established medical practices. Yale professor emeritus Dr. Fred Volkmar noted that the removal of expert committee members in favor of those promoting unproven remedies undermines the integrity of autism research and treatment. He emphasized the importance of evidence-based practices, stating, “It’s a shame that the federal government is not being more helpful to parents in understanding what does and doesn’t work.”

Official Statements & Responses: HHS Defense

In response to the backlash, HHS defended the new committee members, asserting that they are experienced in research and clinical care, committed to advancing innovation in autism treatment. However, this assertion has been met with skepticism from various advocacy groups, who argue that the committee's composition reflects a troubling shift towards alternative medicine.

What's Next: Future Implications

The removal of the FDA's warnings raises questions about the future of autism treatment policies under Kennedy's leadership. As advocates continue to voice their concerns, the potential for further changes in federal health guidelines remains a critical issue. The ongoing debate highlights the need for clear, science-based information regarding autism treatments to protect the health and safety of affected individuals.

Verbatim Quotes

  • “See ProPublica reporting below: Reaction from Kayla Hancock, Director of Public Health Watch, a project of Protect Our Care: “There’s a good reason why the FDA used to warn against treating autism with raw camel milk and industrial strength disinfectants: it could kill you.” — Kayla Hancock, Director of Public Health Watch
  • “It may be an older page, but those warnings are still necessary,” — Zoe Gross, Director at the Autistic Self Advocacy Network
  • “These days, probably 70% to 75% of children on the autism spectrum will grow up to be fully independent or semi-independent adults.” — Dr. Fred Volkmar, Yale University Professor Emeritus

The removal of the FDA's warnings against ineffective autism treatments has ignited a critical discussion about the safety and efficacy of alternative therapies, emphasizing the need for ongoing vigilance and advocacy in public health policy.